Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk?

被引：2
|
作者：
Carney, Dennis A. [1 ]
Seymour, John F. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Dept Haematol, Melbourne 3002, Australia
来源：
LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 11期
关键词：
ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; STEM-CELL MOBILIZATION; NON-HODGKINS-LYMPHOMA; CYCLOPHOSPHAMIDE; MITOXANTRONE; CHLORAMBUCIL; RITUXIMAB; CANCER;
D O I：
10.3109/10428194.2010.514084
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1957 / 1959
页数：3
相关论文
共 50 条
  • [21] Risk of therapy-related myelodysplasia and/or acute myeloid leukemia after autologous stem cell transplantation.
    Beauchamp-Nicoud, A
    Feneux, D
    Bayle, C
    Bernheim, A
    Tchemia, G
    Bourhis, JH
    BLOOD, 2001, 98 (11) : 364B - 364B
  • [22] High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders
    Bowcock, Stella J.
    Rassam, Saad M. B.
    Lim, Ziyi
    Ward, Susan M.
    Ryali, Madan M.
    Mufti, Ghulam J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (02) : 242 - 243
  • [23] THERAPY-RELATED MYELODYSPLASIA: SOMATIC MUTATIONS AND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION OUTCOMES
    Nakamura, R.
    Pham, A.
    Gendzekhadze, K.
    Min, L.
    Pullarkat, V.
    Al Malki, M.
    Donnell, M. O.
    Cao, T.
    Stein, A.
    Khaled, S.
    Ali, H.
    Senitzer, D.
    Afkhami, M. A. Michelle
    Aoun, P.
    Murata-Collins, J.
    Forman, S.
    Palmer, J.
    Marcucci, G.
    Pillai, R.
    Aldoss, I.
    LEUKEMIA RESEARCH, 2017, 55 : S42 - S43
  • [24] The p53 gene in pediatric therapy-related leukemia and myelodysplasia.
    Felix, CA
    Hosler, M
    Provisor, D
    Salhany, K
    Sexsmith, E
    Cheung, NKV
    Winick, NJ
    Strauss, EA
    Heyn, R
    Lange, BJ
    Malkin, D
    BLOOD, 1995, 86 (10) : 2899 - 2899
  • [25] RESPONSE OF THERAPY-RELATED MYELODYSPLASIA TO LOW-DOSE INTERLEUKIN-2
    TOZE, CL
    BARNETT, MJ
    KLINGEMANN, HG
    LEUKEMIA, 1993, 7 (03) : 463 - 465
  • [26] Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia
    Sasaki, Koji
    Jabbour, Elias
    Cortes, Jorge
    Kadia, Tapan
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Jain, Preetesh
    Pierce, Sherry
    Daver, Naval
    Takahashi, Koichi
    O'Brien, Susan
    Kantarjian, Hagop
    Ravandi, Farhad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (11): : 616 - 624
  • [27] Additional attention to combination antiretroviral therapy-related lipodystrophy
    Norihiko Kobayashi
    Masako Nakahara
    Masako Oka
    Kumiko Saeki
    World Journal of Virology, 2017, (03) : 49 - 52
  • [28] Treatment-related myelodysplasia following fludarabine combination chemotherapy
    Tam, Constantine S.
    Seymour, John F.
    Prince, H. Miles
    Kenealy, Melita
    Wolf, Max
    Januszewicz, E. Henry
    Westerman, David
    HAEMATOLOGICA, 2006, 91 (11) : 1546 - 1550
  • [29] Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
    Epperla, Narendranath
    Pham, Anthony Q.
    Burnette, Brian L.
    Wiseman, Gregory A.
    Habermann, Thomas M.
    Macon, William R.
    Ansell, Stephen M.
    Inwards, David J.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Markovic, Svetomir N.
    Porrata, Luis F.
    Colgan, Joseph P.
    Ristow, Kay M.
    Nowakowski, Grzegorz S.
    Witzig, Thomas E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (03) : 427 - 433
  • [30] Risk stratification in therapy-related myelodysplastic syndromes
    Zeidan, Amer M.
    ONCOTARGET, 2017, 8 (46) : 80103 - 80104
12345